FIELD: medicine, oncology. SUBSTANCE: method of treatment of patients with primary liver cancer involves firstly administration of alpha-fetoprotein in physiological solution in hepatic artery followed by administration of an anticancer substance preliminary dissolved in 96% ethyl alcohol where lipiodol ultrafluid is added additionally. An antitumor substance is doxorubicin at the dose 30-40 mg dissolved in 1 ml of 96% ethyl alcohol in 10 ml lipiodol ultrafluid and alpha-fetoprotein is administrated at the dose 2 mg/10 ml of physiological solution. The set for treatment of patients with primary liver cancer has an antitumor agent, 96% ethyl alcohol, lipiodol ultrafluid, alpha-fetoprotein, sterile physiological solution (15 ml in ampoule) where doxorubicin is added as an antitumor agent at amount 30-40 mg in 3-4 flasks (volume is 10 ml), sterile lipiodol ultrafluid (5 ml in 2 ampoules), sterile human preparation of lyophilized alpha-fetoprotein at amount 2 mg in flasks (volume is 1 ml in ampoule). EFFECT: enhanced effectiveness of method, decreased toxicity. 3 cl, 1 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PRIMARY LIVER CANCER TREATMENT AND KIT FOR PRIMARY LIVER CANCER TREATMENT | 1994 |
|
RU2065307C1 |
METHOD TO TREAT MALIGNANT NEOPLASMS AND COMBINED PREPARATION OF ANTITUMOR ACTION TO PERFORM THE METHOD | 2000 |
|
RU2179452C1 |
METHOD OF PURIFICATION OF HUMAN ALPHA-FETOPROTEIN | 1994 |
|
RU2074193C1 |
METHOD OF ANTITUMORAL THERAPY IN CASE OF PRIMARY HEPATIC CARCINOMA | 1993 |
|
RU2026679C1 |
METHOD FOR TREATMENT OF MALIGNANT NEUROENDOCRINAL TUMOURS OF PANCREAS HEAD WITH METASTASES IN LIVER | 2016 |
|
RU2625275C1 |
METHOD OF TREATING MALIGNANT LIVER TUMORS | 2007 |
|
RU2354307C1 |
METHOD FOR TREATING METASTASES OF COLORECTAL CANCER IN THE LIVER | 2017 |
|
RU2663800C2 |
METHOD FOR TREATMENT OF COLORECTAL CANCER METASTASIS IN LIVER | 2003 |
|
RU2241459C2 |
METHOD OF TREATING PATIENTS WITH METASTATIC HEPATIC CANCER | 2013 |
|
RU2554794C1 |
METHOD OF PREPARING PREPARATION FOR DIRECTED DELIVERY OF ANTITUMOR DRUG IN CANCER CELL | 1998 |
|
RU2139083C1 |
Authors
Dates
1999-08-20—Published
1998-12-22—Filed